For companies such as HRV Pharma out of India, the standardized scale of manufacturing has expanded alongside its ...

POTOMAC, MD / ACCESS Newswire / March 4, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC) today announced an advancement in its Artificial Intelligence ("AI") platform with the ...

CinRx Pharma’s formula of scouting for promising drug assets and forming new companies around them has produced five “CinCos,” one of which successfully went public and went on to an acquisition by a ...

Taking over as CEO for an aging company in dire financial straits and in need of a slim-down was a challenging assignment for Christophe Bourdon. But under Bourdon’s watch, Leo Pharma is taking steps ...

We recently compiled a list of the 12 AI Stocks Making Headlines: Latest News and Ratings. In this article, we are going to take a look at where IGC Pharma, Inc. (NYSEAMERICAN:IGC) stands against the ...

At the AXS26 Summit, Wheel’s Chris Moose argued that pharmaceutical companies must abandon outdated, prescription-focused engagement models and meet patients earlier in their decision-making process.

The peptide synthesis market could offer a chance for India to become a hub for precision manufacturing of next-generation ...

Model N’s Michael Grosberg breaks down the accelerated complexity, policy disruption, and data gaps testing manufacturer market access and revenue management strategies. In the debut episode ...

Thank you, Harmony, and thank you, everyone, for joining today's call with Mayne Pharma and DistributeRx executives. It's certainly an exciting period for Mayne Pharma with the launch of DistributeRx ...

We reviewed our model assumptions for narrow-moat CR Pharmaceuticals (or CR Pharma) and revise our fair value estimate downward to HKD 6.40 per share from HKD 11.40 per share. Market sentiment toward ...

The MarketWatch News Department was not involved in the creation of this content. Amid growing regulatory pressures, including IRA pricing reforms, RevSavvy reports increasing adoption of its ARC ...